Cite
Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.
MLA
Young, Jacques, et al. “Hepatic Safety of Ketoconazole in Cushing’s Syndrome: Results of a Compassionate Use Programme in France.” European Journal of Endocrinology, vol. 178, no. 5, May 2018, pp. 447–58. EBSCOhost, https://doi.org/10.1530/EJE-17-0886.
APA
Young, J., Bertherat, J., Vantyghem, M. C., Chabre, O., Senoussi, S., Chadarevian, R., & Castinetti, F. (2018). Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France. European Journal of Endocrinology, 178(5), 447–458. https://doi.org/10.1530/EJE-17-0886
Chicago
Young, Jacques, Jérôme Bertherat, Marie Christine Vantyghem, Olivier Chabre, Salima Senoussi, Rita Chadarevian, and Frédéric Castinetti. 2018. “Hepatic Safety of Ketoconazole in Cushing’s Syndrome: Results of a Compassionate Use Programme in France.” European Journal of Endocrinology 178 (5): 447–58. doi:10.1530/EJE-17-0886.